234 related articles for article (PubMed ID: 14562286)
1. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract.
Abraham SC; Lee JH; Hruban RH; Argani P; Furth EE; Wu TT
Hum Pathol; 2003 Sep; 34(9):902-10. PubMed ID: 14562286
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability in intraductal papillary neoplasms of the biliary tract.
Abraham SC; Lee JH; Boitnott JK; Argani P; Furth EE; Wu TT
Mod Pathol; 2002 Dec; 15(12):1309-17. PubMed ID: 12481012
[TBL] [Abstract][Full Text] [Related]
3. Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways.
Schlitter AM; Born D; Bettstetter M; Specht K; Kim-Fuchs C; Riener MO; Jeliazkova P; Sipos B; Siveke JT; Terris B; Zen Y; Schuster T; Höfler H; Perren A; Klöppel G; Esposito I
Mod Pathol; 2014 Jan; 27(1):73-86. PubMed ID: 23828315
[TBL] [Abstract][Full Text] [Related]
4. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p.
Abraham SC; Wu TT; Klimstra DS; Finn LS; Lee JH; Yeo CJ; Cameron JL; Hruban RH
Am J Pathol; 2001 Nov; 159(5):1619-27. PubMed ID: 11696422
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
6. Recurrent Mutations in APC and CTNNB1 and Activated Wnt/β-catenin Signaling in Intraductal Papillary Neoplasms of the Bile Duct: A Whole Exome Sequencing Study.
Fujikura K; Akita M; Ajiki T; Fukumoto T; Itoh T; Zen Y
Am J Surg Pathol; 2018 Dec; 42(12):1674-1685. PubMed ID: 30212390
[TBL] [Abstract][Full Text] [Related]
7. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.
Abraham SC; Wu TT; Hruban RH; Lee JH; Yeo CJ; Conlon K; Brennan M; Cameron JL; Klimstra DS
Am J Pathol; 2002 Mar; 160(3):953-62. PubMed ID: 11891193
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma.
Sugimachi K; Taguchi K; Aishima S; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2001 Sep; 14(9):900-5. PubMed ID: 11557787
[TBL] [Abstract][Full Text] [Related]
9. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A
Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterisation of six human biliary tract cancer cell lines.
Ku JL; Yoon KA; Kim IJ; Kim WH; Jang JY; Suh KS; Kim SW; Park YH; Hwang JH; Yoon YB; Park JG
Br J Cancer; 2002 Jul; 87(2):187-93. PubMed ID: 12107841
[TBL] [Abstract][Full Text] [Related]
12. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.
Abraham SC; Klimstra DS; Wilentz RE; Yeo CJ; Conlon K; Brennan M; Cameron JL; Wu TT; Hruban RH
Am J Pathol; 2002 Apr; 160(4):1361-9. PubMed ID: 11943721
[TBL] [Abstract][Full Text] [Related]
13. GNAS Is frequently mutated in a specific subgroup of intraductal papillary neoplasms of the bile duct.
Tsai JH; Yuan RH; Chen YL; Liau JY; Jeng YM
Am J Surg Pathol; 2013 Dec; 37(12):1862-70. PubMed ID: 24061513
[TBL] [Abstract][Full Text] [Related]
14. Low frequency of p53 and ras mutations in bile of patients with hepato-biliary disease: a prospective study in more than 100 patients.
Müller P; Ostwald C; Püschel K; Brinkmann B; Plath F; Kröger J; Barten M; Nizze H; Schareck WD; Hauenstein K; Liebe S; Löhr JM
Eur J Clin Invest; 2001 Mar; 31(3):240-7. PubMed ID: 11264652
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
Sasaki M; Sato Y
Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
[TBL] [Abstract][Full Text] [Related]
16. GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct.
Matthaei H; Wu J; Dal Molin M; Debeljak M; Lingohr P; Katabi N; Klimstra DS; Adsay NV; Eshleman JR; Schulick RD; Kinzler KW; Vogelstein B; Hruban RH; Maitra A
HPB (Oxford); 2012 Oct; 14(10):677-83. PubMed ID: 22954004
[TBL] [Abstract][Full Text] [Related]
17. Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases.
Schlitter AM; Jang KT; Klöppel G; Saka B; Hong SM; Choi H; Offerhaus GJ; Hruban RH; Zen Y; Konukiewitz B; Regel I; Allgäuer M; Balci S; Basturk O; Reid MD; Esposito I; Adsay V
Mod Pathol; 2015 Sep; 28(9):1249-64. PubMed ID: 26111977
[TBL] [Abstract][Full Text] [Related]
18. RNF43 mutation frequently occurs with GNAS mutation and mucin hypersecretion in intraductal papillary neoplasms of the bile duct.
Tsai JH; Liau JY; Yuan CT; Cheng ML; Yuan RH; Jeng YM
Histopathology; 2017 Apr; 70(5):756-765. PubMed ID: 27864998
[TBL] [Abstract][Full Text] [Related]
19. Different carcinogenic process in cholangiocarcinoma cases epidemically developing among workers of a printing company in Japan.
Sato Y; Kubo S; Takemura S; Sugawara Y; Tanaka S; Fujikawa M; Arimoto A; Harada K; Sasaki M; Nakanuma Y
Int J Clin Exp Pathol; 2014; 7(8):4745-54. PubMed ID: 25197345
[TBL] [Abstract][Full Text] [Related]
20. Alteration of the fragile histidine triad gene in intrahepatic cholangiocarcinoma.
Koch E; Fiedler W; Tannapfel A; Ballhausen WG
Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):907-13. PubMed ID: 12867802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]